The company also has a R&D center
in India that conducts research in rabies, hepatitis b and measles
and human biologicals manufacturer
Road # 44, Jubilee Hills, Hyderabad – 500033,
Clocking an estimated revenue of
Indian Immunologicals has shown improvement from 2009-10 revenue of
272.87 crore. With an aim to make
immunity affordable to both animal
and humans alike, Indian Immunologicals, has grown to be one of the
largest biologicals company in
India since its inception in 1983.
In 2010, the company introduced Folyson, a dairy cattle hormone, which
indirectly enhances the milk production capacity of a dairy cow or
Furthermore, motivated by the success of the foot and mouth disease
vaccine, Raksha, the company went on to launch its tissue culture
vaccine, Raksharab, and also successfully produced and marketed its
human anti-rabies vaccine, called Abhayrab.
With a 213-acre complex in Hyderabad, which has the distinction of
being WHO-GMP and ISO-9002 certified,
Indian Immunologicals has one of the world’s largest veterinary vaccine
plants in the world, equipped with state-of-the-art technology to
manufacture and market vaccines to the masses.
In the animal health sector, Indian Immunologicals manufactures
vaccines for foot and mouth diseases, clostridium perfringens, sheep
brucella abortus, theileriosis and bacillus anthracis among others. It
is also actively engaged in the production of other animal health
In the human health sector, Indian Immunologicals has made a
significant progress through its cell culture rabies vaccine, Abhayrab.
This vaccine is sold by Abhay Clinics, which belong to the marketing
network of Indian Immunologicals. The success of this anti-rabies
vaccine has influenced the company to venture deeper into this domain
by establishing two manufacturing facilities, one in Ooty and another
in Hyderabad, India.
The manufacturing facility of the company that is located in Hyderabad
is equipped to produce vaccines such as hepatitis-b, diphtheria,
pertussis, tetanus and measles. The company has another R&D center
in India that conducts research in rabies, hepatitis b and
measles among others.
The company’s marketing network is widespread with over 19 marketing
outlets spread across India. In addition to the domestic network, the
company also has significant export connections, supplying animal
health vaccines to over 20 countries apart from the Food and
Agriculture Organization (FAO) of the US. More than 12 countries across
the world are receivers of Indian Immunologicals’ human anti-rabies
vaccine, Abhayrab. The export market
of the company is extremely diversified. It is spread across several
countries including, the Gulf, Asia, Africa, Europe, Russia and other
The company has research collaborations with several renowned
institutions like Thomas Jefferson Medical School, Onderstepoort
Veterinary Institute and Institute of Animal Health among others.
Indian Immunologicals aims to combat infectious diseases in animals and
human beings by producing affordable products for the betterment of